225 related articles for article (PubMed ID: 8890771)
1. Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.
Whitehead AS; Bertrandy S; Finnan F; Butler A; Smith GD; Ben-Shlomo Y
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):347-51. PubMed ID: 8890771
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease.
Ibarreta D; Gómez-Isla T; Portera-Sánchez A; Parrilla R; Ayuso MS
J Neurol Sci; 1995 Dec; 134(1-2):146-9. PubMed ID: 8747858
[TBL] [Abstract][Full Text] [Related]
3. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.
Marder K; Maestre G; Cote L; Mejia H; Alfaro B; Halim A; Tang M; Tycko B; Mayeux R
Neurology; 1994 Jul; 44(7):1330-1. PubMed ID: 8035940
[TBL] [Abstract][Full Text] [Related]
4. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
[TBL] [Abstract][Full Text] [Related]
5. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.
Hardy J; Crook R; Prihar G; Roberts G; Raghavan R; Perry R
Neurosci Lett; 1994 Nov; 182(1):1-2. PubMed ID: 7891871
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.
Gearing M; Schneider JA; Rebeck GW; Hyman BT; Mirra SS
Neurology; 1995 Nov; 45(11):1985-90. PubMed ID: 7501146
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.
de la Fuente-Fernández R; Núñez MA; López E
Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253
[TBL] [Abstract][Full Text] [Related]
8. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.
Williams-Gray CH; Goris A; Saiki M; Foltynie T; Compston DA; Sawcer SJ; Barker RA
J Neurol; 2009 Mar; 256(3):493-8. PubMed ID: 19308307
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group.
The F
J Neurol Neurosurg Psychiatry; 1997 Sep; 63(3):394-5. PubMed ID: 9328263
[TBL] [Abstract][Full Text] [Related]
12. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotypes in Parkinson's disease with and without dementia.
Koller WC; Glatt SL; Hubble JP; Paolo A; Tröster AI; Handler MS; Horvat RT; Martin C; Schmidt K; Karst A
Ann Neurol; 1995 Feb; 37(2):242-5. PubMed ID: 7847865
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.
Morris CM; Massey HM; Benjamin R; Leake A; Broadbent C; Griffiths M; Lamb H; Brown A; Ince PG; Tyrer S; Thompson P; McKeith IG; Edwardson JA; Perry RH; Perry EK
J Neural Transm Suppl; 1996; 47():205-18. PubMed ID: 8841967
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
17. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
Landén M; Thorsell A; Wallin A; Blennow K
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
[TBL] [Abstract][Full Text] [Related]
19. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
Peplonska B; Safranow K; Gaweda-Walerych K; Maruszak A; Czyzewski K; Rudzinska M; Barcikowska M; Zekanowski C
Neurobiol Aging; 2013 Aug; 34(8):2078.e1-2. PubMed ID: 23522842
[TBL] [Abstract][Full Text] [Related]
20. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
